Recombinant Human Transmembrane O-methyltransferase (LRTOMT)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Human Transmembrane O-methyltransferase (LRTOMT)

Recombinant Human Transmembrane O-methyltransferase, encoded by the LRTOMT gene, is a unique protein that combines leucine-rich transmembrane domains with an O-methyltransferase domain. This gene is associated with profound non-syndromic hearing loss, particularly at the DFNB63 locus on human chromosome 11q13.3-q13.4 . The LRTOMT protein exhibits dual functions, suggesting its involvement in both structural roles within the cell membrane and enzymatic activities related to catechol-O-methylation .

Gene Structure

The LRTOMT gene contains ten exons, which give rise to five alternatively spliced transcripts. These transcripts encode different isoforms of the protein, with variations in their structure and potential function .

Protein Structure and Localization

LRTOMT proteins are detected in various tissues, including the liver, kidney, and spleen. In the inner ear, LRTOMT is localized to the cytoplasm of inner and outer hair cells and their supporting cells, suggesting a role in auditory function . The protein's structure includes a leucine-rich repeat domain and a catechol-O-methyltransferase-like domain, which may be involved in methylation reactions similar to those catalyzed by catechol-O-methyltransferase (COMT) .

Enzymatic Activity

The O-methyltransferase domain of LRTOMT shows homology with COMT, suggesting it may participate in similar biochemical pathways. This domain is hypothesized to contribute to residual methyltransferase activity observed in COMT-deficient models .

Pathogenic Variants and Hearing Loss

Mutations in the LRTOMT gene have been identified as causes of autosomal recessive non-syndromic hearing loss. Specific mutations, such as c.242G>A, c.313T>C, and c.328G>A, lead to amino acid substitutions that disrupt protein function . These mutations result in nonconservative changes that likely impair the protein's role in maintaining auditory function.

Genetic Studies

Genetic analyses have revealed that mutations in LRTOMT are associated with hearing loss in several families worldwide. These studies highlight the importance of LRTOMT in auditory function and suggest that mutations in this gene could be a common cause of non-syndromic hearing loss .

Molecular Mechanisms

The dual nature of LRTOMT, combining structural and enzymatic functions, makes it a fascinating subject for studying the molecular mechanisms underlying hearing loss. Further research into how mutations affect these functions could provide insights into potential therapeutic targets .

Table 1: Known Mutations in LRTOMT Associated with Hearing Loss

MutationAmino Acid ChangePhenotype
c.242G>Ap.R81QHearing Loss
c.313T>Cp.W105RHearing Loss
c.328G>Ap.E110KHearing Loss

Table 2: Tissue Distribution of LRTOMT

TissueProtein Detection
LiverYes
KidneyYes
SpleenYes
Inner Ear CellsYes

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
If you require a specific tag, please inform us for preferential development.
Synonyms
TOMT; COMT2; LRTOMT; PP7517; Transmembrane O-methyltransferase; Catechol O-methyltransferase 2; Protein LRTOMT2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-291
Protein Length
full length protein
Species
Homo sapiens (Human)
Target Names
LRTOMT
Target Protein Sequence
MGTPWRKRKGIAGPGLPDLSCALVLQPRAQVGTMSPAIALAFLPLVVTLLVRYRHYFRLL VRTVLLRSLRDCLSGLRIEERAFSYVLTHALPGDPGHILTTLDHWSSRCEYLSHMGPVKG QILMRLVEEKAPACVLELGTYCGYSTLLIARALPPGGRLLTVERDPRTAAVAEKLIRLAG FDEHMVELIVGSSEDVIPCLRTQYQLSRADLVLLAHRPRCYLRDLQLLEAHALLPAGATV LADHVLFPGAPRFLQYAKSCGRYRCRLHHTGLPDFPAIKDGIAQLTYAGPG
Uniprot No.

Target Background

Function
Recombinant Human Transmembrane O-methyltransferase (LRTOMT) catalyzes the O-methylation and inactivation of catecholamine neurotransmitters and catechol hormones. It is essential for auditory function as a component of the cochlear hair cell's mechanotransduction (MET) machinery, specifically in the assembly of the asymmetric tip-link MET complex. LRTOMT is required for the transport of TMC1 and TMC2 proteins into the mechanically sensitive stereocilia of hair cells. Notably, its function in MET is independent of its enzymatic activity.
Gene References Into Functions
  1. Mutations in the LRTOMT gene alter the LRTOMT2 protein and may contribute to progressive sensorineural hearing loss. PMID: 25788562
  2. LRTOMT gene mutations are the second leading cause of congenital hearing impairment in Moroccan patients. PMID: 23053991
  3. A 1 bp deletion in the LRTOMT gene causes a frameshift mutation, impacting both reading frames. PMID: 21739586
  4. Genome-wide linkage analysis identified DFNB63, a locus for congenital profound sensorineural hearing loss, linked to the LRTOMT gene. PMID: 17066295
  5. Haplotype analysis revealed a 5.55 Mb critical region on chromosome 11. PMID: 17166180
  6. The locus associated with ARNSHI. PMID: 17211611
  7. A nonsense mutation in the human LRTOMT gene (orthologous to murine Comt2) causes nonsyndromic deafness. PMID: 18794526
  8. LRTOMT mutations are associated with profound nonsyndromic hearing loss at the DFNB63 locus on chromosome 11q13.3-q13.4. PMID: 18953341
Database Links

HGNC: 25033

OMIM: 611451

KEGG: hsa:220074

STRING: 9606.ENSP00000305742

UniGene: Hs.317243

Involvement In Disease
Deafness, autosomal recessive, 63 (DFNB63)
Protein Families
Class I-like SAM-binding methyltransferase superfamily, Cation-dependent O-methyltransferase family
Subcellular Location
[Isoform 1]: Membrane; Single-pass membrane protein.; [Isoform 2]: Cytoplasm. Endoplasmic reticulum.

Q&A

What is TOMT/LRTOMT and what is its biological function?

TOMT (Transmembrane O-Methyltransferase) is a catechol-O-methyltransferase that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a hydroxyl group of catechols. This enzyme is essential for auditory and vestibular function in humans. From a functional perspective, TOMT is required for auditory function and serves as a component of the cochlear hair cell's mechanotransduction (MET) machinery. The gene is involved in the assembly of the asymmetric tip-link MET complex and is required for transportation of TMC1 and TMC2 proteins into the mechanically sensitive stereocilia of the hair cells. Interestingly, this function in mechanotransduction appears to be independent of its enzymatic activity .

Mutations in the TOMT gene have been associated with nonsyndromic deafness, particularly Deafness, Autosomal Recessive 63. The gene also exhibits readthrough transcription with the adjacent leucine-rich repeat containing 51 gene (LRRC51), which forms the basis of the alternative name LRTOMT .

How does TOMT differ structurally and functionally from other methyltransferases?

While TOMT shares the basic catalytic mechanism with other methyltransferases like COMT (an important paralog), it possesses unique structural and functional characteristics:

  • Membrane localization: Unlike soluble COMT (S-COMT), TOMT is a transmembrane protein similar to membrane-bound COMT (MB-COMT), but with specific localization in cochlear hair cells .

  • Substrate specificity: Though both enzymes catalyze O-methylation reactions, TOMT has evolved specific substrate preferences related to its role in auditory function .

  • Functional independence: Unlike COMT, whose enzymatic activity is central to its biological role, TOMT's function in mechanotransduction can be independent of its methyltransferase activity, suggesting additional structural or scaffolding roles .

  • Disease associations: While COMT is primarily linked to neurological conditions like Parkinson's disease and schizophrenia, TOMT mutations specifically lead to hearing impairments .

What gene and protein identifiers are associated with human TOMT?

The following identifiers are critical for researchers working with TOMT in various databases and platforms:

Database/ResourceIdentifier
HGNC55527
NCBI Gene120356740
EnsemblENSG00000284844
UniProtKB/Swiss-ProtQ8WZ04
Previous GeneCardsGC11P072108, GC11P072111, GC11P072665, GC11P072270, GC11P080168, GC11P082307, GC11P084877

These identifiers are essential for database searches, literature reviews, and designing experiments targeting this gene or protein .

What expression systems are most effective for producing recombinant human TOMT?

Based on successful approaches with related membrane-bound methyltransferases, several expression systems can be considered for TOMT:

Yeast Expression System (Pichia pastoris):
P. pastoris has proven effective for membrane-bound methyltransferases due to its ability to perform post-translational modifications and grow to high cell densities. For optimal TOMT expression in P. pastoris bioreactors, the following parameters should be considered:

  • Culture strategy: Implement a batch growth on glycerol until dissolved oxygen spike, followed by glycerol feeding (approximately 3 hours) and methanol induction (12 hours) .

  • Optimization parameters:

    • Temperature: 30°C appears optimal based on similar membrane-bound methyltransferases

    • DMSO concentration: 6% (v/v) enhances membrane protein expression

    • Methanol flow rate: Approximately 2.9 mL/L/H constant flow-rate

This approach has shown a 6.4-fold improvement in specific activity for membrane-bound methyltransferases compared to small-scale biosynthesis in baffled shake-flasks .

Gene Copy Number Considerations:
When designing expression vectors, multiple gene copies can potentially enhance expression. Studies with similar methyltransferases have shown successful integration of 9-10 copies of the target plasmid in P. pastoris strains (both Mut+ X33 and MutS KM71H) .

What analytical methods can be used to measure TOMT enzymatic activity?

Several methodologies can be adapted from COMT research to assess TOMT activity with high sensitivity and specificity:

1. Liquid Chromatography-Fluorescence Detection (LC-FD) Assays:
This approach offers high sensitivity with detection limits around 0.1 pmol of methylated product. Two strategies can be employed:

  • Native fluorescence detection: If using catecholamine substrates (like norepinephrine or dopamine), their O-methylated products exhibit natural fluorescence .

  • Derivatization approach: Non-fluorescent substrates like 3,4-dihydroxybenzaldehyde (DHBAd) can be detected after methylation and derivatization with fluorogenic reagents such as 2,2′-dithiobis (1-aminonaphthalene) (DTAN) .

2. Fluorogenic Probe Substrates:
These purpose-designed substrates generate strongly fluorescent products upon methylation by TOMT:

SubstrateChemical Structure TypeMetabolic Siteλ ex./em. (nm)Expected Km Range
DHMCCoumarin-based8-OH320/5104-6 μM
3-BTDBenzothiazole-coumarin8-OH390/5200.7-0.9 μM

The 3-BTD probe offers two-photon absorption and emission properties, making it suitable for in vivo imaging applications and deep tissue penetration .

How can researchers overcome challenges in studying membrane-bound TOMT?

Membrane-bound methyltransferases present several experimental challenges that require specific strategies:

Protein Solubilization and Purification:

  • Employ detergent screening (DDM, LDAO, CHAPS) to identify optimal solubilization conditions

  • Consider using nanodiscs or styrene maleic acid lipid particles (SMALPs) to maintain native-like lipid environment

  • Implement gentle purification protocols with stabilizing agents to preserve enzymatic activity

2. Structural Characterization:
Since membrane proteins like TOMT are challenging for traditional structural biology approaches, consider:

  • Cryo-electron microscopy (cryo-EM) for structural determination without crystallization

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to probe conformational dynamics

  • In silico modeling based on COMT structural templates with refinement for TOMT-specific features

3. Functional Assays in Native-like Environment:
For studying TOMT's role in mechanotransduction:

  • Develop reconstituted proteoliposome systems incorporating TOMT with potential interaction partners

  • Implement patch-clamp fluorometry to simultaneously monitor protein function and conformational changes

  • Design FRET-based assays to investigate TOMT interaction with TMC1/TMC2 proteins

What is known about TOMT's role in auditory mechanotransduction?

TOMT plays a critical role in auditory function through multiple mechanisms:

  • Tip-link MET Complex Assembly: TOMT is involved in the assembly of the asymmetric tip-link mechanotransduction complex in cochlear hair cells, which is essential for proper sound sensing .

  • Protein Transport Function: TOMT is required for the transportation of TMC1 and TMC2 proteins into the mechanically sensitive stereocilia of the hair cells. These proteins are critical components of the mechanotransduction channel complex .

  • Enzymatic Activity-Independent Function: Interestingly, TOMT's function in mechanotransduction appears to be independent of its enzymatic (methyltransferase) activity, suggesting it may serve as a chaperone or scaffold protein in addition to its catalytic role .

  • Disease Mechanism: Mutations in TOMT lead to Deafness, Autosomal Recessive 63, with specific defects in hair cell mechanotransduction. This indicates that TOMT function cannot be compensated by other methyltransferases like COMT despite similar catalytic activities .

What methodological approaches can be used to study TOMT's catalytic mechanism?

Understanding TOMT's catalytic mechanism requires multiple complementary approaches:

1. Kinetic Analysis:
Based on knowledge from related methyltransferases, TOMT likely follows an ordered Bi-Bi mechanism where SAM binds first, followed by the catechol substrate, forming a ternary complex before product release .

2. Structural Requirements for Catalysis:
The catalytic site likely includes:

  • A magnesium coordination center involving aspartate and asparagine residues

  • A lysine residue (corresponding to Lys144 in COMT) that plays a pivotal role in the O-methylation reaction

  • Specific binding pockets for SAM and the catechol substrate

Experimental Approaches:

  • Site-directed mutagenesis of predicted catalytic residues

  • Pre-steady-state kinetics to capture transient catalytic intermediates

  • pH-dependent activity profiles to identify critical ionizable groups

  • Isothermal titration calorimetry (ITC) to characterize substrate binding thermodynamics

4. Visualization of TOMT Activity:
For in situ detection of enzymatic activity, researchers can adapt the two-photon fluorescent probe approach using 3-(benzo[d]thiazol-2-yl)-7,8-dihydroxy-2H-chromen-2-one (3-BTD), which has been successfully applied to visualize methyltransferase activity in living cells and tissues .

What are the optimal buffer conditions for maintaining TOMT stability and activity?

Based on research with related methyltransferases, the following buffer conditions likely support TOMT stability and activity:

Buffer ComponentRecommended RangePurpose
Buffer type50-100 mM phosphate or Tris, pH 7.4-8.0Maintain physiological pH
MgCl₂2-5 mMEssential cofactor for catalysis
NaCl50-150 mMIonic strength stabilization
Glycerol10-20%Prevent protein aggregation
Reducing agent1-5 mM DTT or 0.5-2 mM TCEPMaintain thiol groups
Detergent (for purified protein)0.01-0.05% DDM or LDAOMaintain membrane protein solubility

For enzymatic activity assays, additional components would include:

  • 50-200 μM S-adenosyl-L-methionine (SAM) as methyl donor

  • Catechol substrate (concentration depending on Km)

  • Possible addition of 5-10% DMSO to improve substrate solubility

How can researchers differentiate between TOMT's enzymatic and non-enzymatic functions?

Differentiating between TOMT's dual roles requires careful experimental design:

1. Catalytically Inactive Mutants:
Generate mutants with point mutations in the catalytic site (based on COMT homology) that eliminate enzymatic activity while maintaining protein structure. These mutants can be tested for:

  • In vitro methyltransferase activity (should be absent)

  • Ability to rescue TMC1/TMC2 transport in TOMT-knockout models

  • Capacity to restore mechanotransduction in deficient hair cells

Domain-Specific Analysis:

  • Create chimeric proteins swapping domains between TOMT and COMT

  • Generate truncation mutants to identify regions essential for protein-protein interactions

  • Perform domain-specific cross-linking to capture interaction partners

Functional Readouts:

  • Fluorescence-based trafficking assays to monitor TMC1/TMC2 localization

  • Electrophysiological recordings to assess mechanotransduction channel function

  • FRET-based interaction assays to measure protein-protein binding dynamics

This multi-faceted approach can help delineate which functions of TOMT depend on its catalytic activity versus its structural or scaffolding properties .

How do TOMT mutations correlate with auditory phenotypes in Deafness, Autosomal Recessive 63?

Understanding genotype-phenotype correlations for TOMT mutations provides insight into both clinical management and fundamental mechanisms:

  • Mutation Classification:

    • Catalytic domain mutations: May primarily affect enzymatic activity

    • Transmembrane domain mutations: Likely disrupt protein localization

    • Truncation mutations: Typically result in complete loss of function

    • Missense mutations: Can have variable effects depending on location

  • Auditory Phenotype Assessment:

    • Audiometric testing to quantify hearing thresholds across frequencies

    • Otoacoustic emissions to assess outer hair cell function

    • Auditory brainstem responses to evaluate neural transmission

    • Vestibular testing to identify balance disturbances

  • Research Approaches:

    • Patient-derived iPSCs differentiated into inner ear organoids

    • CRISPR-engineered mouse models carrying human mutations

    • High-resolution imaging of hair cell structure in model systems

This research area offers potential for gene therapy approaches targeting TOMT-associated hearing loss .

How does TOMT activity compare with COMT in drug metabolism studies?

While COMT is a well-established target for Parkinson's disease therapy, TOMT's potential role in drug metabolism requires investigation:

  • Substrate Specificity Comparison:
    Using validated fluorogenic substrates like DHMC and 3-BTD, comparative kinetic analysis between TOMT and COMT can reveal:

    • Differences in substrate preference

    • Variation in catalytic efficiency (kcat/Km)

    • Distinct inhibitor sensitivity profiles

  • Inhibitor Cross-Reactivity:

    • Evaluate whether established COMT inhibitors (entacapone, tolcapone) affect TOMT activity

    • Screen for TOMT-selective inhibitors using high-throughput fluorescence assays

    • Assess off-target effects of COMT inhibitors on auditory function

  • Tissue-Specific Expression Patterns:
    While COMT is widely distributed in both brain and peripheral tissues (with MB-COMT predominating in brain and S-COMT in peripheral tissues), TOMT has more specialized expression, primarily in auditory tissues. This distinction has important implications for targeted drug delivery and potential side effects of methyltransferase inhibitors .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.